Small-molecule screen reveals synergy of cell cycle checkpoint kinase inhibitors with DNA-damaging chemotherapies in medulloblastoma is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 49 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: CA-09832
National Cancer Institute
Grant: CA-02165
National Cancer Institute
Grant: CA159859
National Cancer Institute
Grant: CA30199
Innovative Medicines Initiative
Grant: 116064
Cancer Australia
Grant: 1101390
Cancer Australia
Grant: 1147153
Cancer Council Western Australia
Grant: 1129386
NCI NIH HHS
Grant: P01 CA096832
NCI NIH HHS
Grant: P30 CA030199
NCI NIH HHS
Grant: R01 CA159859
FWCI
4.19
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals